We have a proud tradition in developing novel treatments for stroke. Augusta University has a long tradition of investigator-initiated stroke clinical stroke trials, translational stroke research, and both leading and participating in NIH-sponsored cooperative trials. Our activities have spanned the phases of clinical trial activities from a strong pre-clinical “translational” program that has developed the scientific rationale and premise for clinical trials, to phase I and II trials that have established dosing, safety and pharmacokinetics, and finally to phase III trials designed and initiated to establish efficacy.
PISCES III : A CLINICAL RESEARCH STUDY OF STEM CELLS FOR PATIENTS WITH ONGOING DISABILITY AFTER STROKE
**Right now this phase of the trial only accepts patients that have had a stroke in the last 6-12 months.